187 related articles for article (PubMed ID: 16434500)
1. Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF-kappaB in mice administered the peroxisome proliferator Wy-14,643.
Glauert HP; Eyigor A; Tharappel JC; Cooper S; Lee EY; Spear BT
Toxicol Sci; 2006 Apr; 90(2):331-6. PubMed ID: 16434500
[TBL] [Abstract][Full Text] [Related]
2. Cell proliferation and apoptosis are altered in mice deficient in the NF-kappaB p50 subunit after treatment with the peroxisome proliferator ciprofibrate.
Tharappel JC; Nalca A; Owens AB; Ghabrial L; Konz EC; Glauert HP; Spear BT
Toxicol Sci; 2003 Oct; 75(2):300-8. PubMed ID: 12883078
[TBL] [Abstract][Full Text] [Related]
3. WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase.
Woods CG; Burns AM; Bradford BU; Ross PK; Kosyk O; Swenberg JA; Cunningham ML; Rusyn I
Toxicol Sci; 2007 Aug; 98(2):366-74. PubMed ID: 17483499
[TBL] [Abstract][Full Text] [Related]
4. Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators.
Rusyn I; Yamashina S; Segal BH; Schoonhoven R; Holland SM; Cattley RC; Swenberg JA; Thurman RG
Cancer Res; 2000 Sep; 60(17):4798-803. PubMed ID: 10987289
[TBL] [Abstract][Full Text] [Related]
5. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver.
Cattley RC; Popp JA
Cancer Res; 1989 Jun; 49(12):3246-51. PubMed ID: 2566380
[TBL] [Abstract][Full Text] [Related]
6. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643.
Rose ML; Germolec D; Arteel GE; Schoonhoven R; Thurman RG
Chem Res Toxicol; 1997 Oct; 10(10):1198-204. PubMed ID: 9348444
[TBL] [Abstract][Full Text] [Related]
7. WY-14,643-mediated promotion of hepatocarcinogenesis in connexin32-wild-type and connexin32-null mice.
Moennikes O; Stahl S; Bannasch P; Buchmann A; Schwarz M
Carcinogenesis; 2003 Sep; 24(9):1561-5. PubMed ID: 12819187
[TBL] [Abstract][Full Text] [Related]
8. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
Marsman DS; Cattley RC; Conway JG; Popp JA
Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084
[TBL] [Abstract][Full Text] [Related]
9. Role of the p50 subunit of NF-kappaB in vitamin E-induced changes in mice treated with the peroxisome proliferator, ciprofibrate.
Calfee-Mason KG; Lee EY; Spear BT; Glauert HP
Food Chem Toxicol; 2008 Jun; 46(6):2062-73. PubMed ID: 18336980
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the promotion of hepatocarcinogenesis by 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153) by the deletion of the p50 subunit of NF-kappa B in mice.
Glauert HP; Tharappel JC; Banerjee S; Chan NL; Kania-Korwel I; Lehmler HJ; Lee EY; Robertson LW; Spear BT
Toxicol Appl Pharmacol; 2008 Oct; 232(2):302-8. PubMed ID: 18644402
[TBL] [Abstract][Full Text] [Related]
11. Activation of peroxisome proliferator-activated receptor alpha enhances apoptosis in the mouse liver.
Xiao S; Anderson SP; Swanson C; Bahnemann R; Voss KA; Stauber AJ; Corton JC
Toxicol Sci; 2006 Aug; 92(2):368-77. PubMed ID: 16687391
[TBL] [Abstract][Full Text] [Related]
12. Effect of phenobarbital on hepatic cell proliferation and apoptosis in mice deficient in the p50 subunit of NF-kappaB.
Tharappel JC; Spear BT; Glauert HP
Toxicol Appl Pharmacol; 2008 Feb; 226(3):338-44. PubMed ID: 17963809
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms for the pancreatic oncogenic effects of the peroxisome proliferator Wyeth-14,643.
Obourn JD; Frame SR; Bell RH; Longnecker DS; Elliott GS; Cook JC
Toxicol Appl Pharmacol; 1997 Aug; 145(2):425-36. PubMed ID: 9266817
[TBL] [Abstract][Full Text] [Related]
14. Evidence that reduction of hepatocyte growth factor (HGF) is not required for peroxisome proliferator-induced hepatocyte proliferation.
Kiss A; Ortiz-Aguayo R; Sharp R; Merlino G; Thorgeirsson SS; Gonzalez FJ; Peters JM
Carcinogenesis; 2001 Jun; 22(6):975-9. PubMed ID: 11375907
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic effects of the continuous exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent upon peroxisome proliferator activated receptor alpha.
Pogribny IP; Tryndyak VP; Woods CG; Witt SE; Rusyn I
Mutat Res; 2007 Dec; 625(1-2):62-71. PubMed ID: 17586532
[TBL] [Abstract][Full Text] [Related]
16. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
Hays T; Rusyn I; Burns AM; Kennett MJ; Ward JM; Gonzalez FJ; Peters JM
Carcinogenesis; 2005 Jan; 26(1):219-27. PubMed ID: 15447978
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the species-specificity of peroxisome proliferators in rat and human hepatocytes.
Ammerschlaeger M; Beigel J; Klein KU; Mueller SO
Toxicol Sci; 2004 Apr; 78(2):229-40. PubMed ID: 14976357
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats.
Biegel LB; Hurtt ME; Frame SR; O'Connor JC; Cook JC
Toxicol Sci; 2001 Mar; 60(1):44-55. PubMed ID: 11222872
[TBL] [Abstract][Full Text] [Related]
19. Cell death and proliferation in NF-kappaB p50 knockout mouse after cerebral ischemia.
Li J; Lu Z; Li WL; Yu SP; Wei L
Brain Res; 2008 Sep; 1230():281-9. PubMed ID: 18657523
[TBL] [Abstract][Full Text] [Related]
20. Toxic effects of fumonisin in mouse liver are independent of the peroxisome proliferator-activated receptor alpha.
Voss KA; Liu J; Anderson SP; Dunn C; Miller JD; Owen JR; Riley RT; Bacon CW; Corton JC
Toxicol Sci; 2006 Jan; 89(1):108-19. PubMed ID: 16221962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]